Nautilus Biotechnology to Participate in Upcoming August Investor Conferences
August 07, 2023 at 07:17 pm IST
Share
SEATTLE - Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or 'Nautilus'), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences: Canaccord 43rd Annual Growth Conference in Boston, MA
Management will participate in 'The Next Generation of Proteomics from the Research and Clinical Perspectives' Panel on Thursday, August 10th at 10:00 a.m. Eastern Time
UBS MedTech, Tools and Genomics Summit 2023 in Dana Point, CA Management will host 1x1 investor meetings on Tuesday, August 15th About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine.
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform end-to-end solution comprised of the proteome analysis system, consumables, and software. The Companyâs products include Proteome Analysis System, and Reagent Kits. Its proteome analysis system is a high-resolution optical imaging system coupled with integrated fluidics and liquid handling sub-systems. The Companyâs Reagent Kits are comprised of four main components: sample preparation, flow cell(s), multi-affinity probe reagents, and instrument buffers used to perform multi-cycle analysis runs.